2-60793628-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022894.4(PAPOLG):c.1681A>G(p.Asn561Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022894.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAPOLG | NM_022894.4 | c.1681A>G | p.Asn561Asp | missense_variant, splice_region_variant | 18/22 | ENST00000238714.8 | NP_075045.2 | |
PAPOLG | XM_005264500.5 | c.1681A>G | p.Asn561Asp | missense_variant, splice_region_variant | 18/21 | XP_005264557.1 | ||
PAPOLG | XM_005264501.3 | c.1549A>G | p.Asn517Asp | missense_variant, splice_region_variant | 18/22 | XP_005264558.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPOLG | ENST00000238714.8 | c.1681A>G | p.Asn561Asp | missense_variant, splice_region_variant | 18/22 | 1 | NM_022894.4 | ENSP00000238714 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.1681A>G (p.N561D) alteration is located in exon 18 (coding exon 18) of the PAPOLG gene. This alteration results from a A to G substitution at nucleotide position 1681, causing the asparagine (N) at amino acid position 561 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at